Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Language barriers: Obesity has become a loaded word

White Papers and Resources | December 5, 2019 | Say Communications

We have a worldwide ‘obesity crisis’. Everyone knows this; obesity is in the news almost every week for one reason or another, but what we seem less sure of is...

Spotlight interview: 15 minutes on digital in medical communications

White Papers and Resources | December 5, 2019 | OPEN Health

Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

Generating data on long-term outcomes with gene and other advanced therapies

White Papers and Resources | December 5, 2019 | OPEN Health

Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.

Behavioural Science in Healthcare

White Papers and Resources | December 4, 2019 | Page & Page Health

Personal health and wellbeing has never been more a part of the public conscious than it is now.

Why aren’t doctors using digital therapeutics?

White Papers and Resources | December 4, 2019 | Blue Latitude Health

The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...

Four Health wins Judges Special Recognition Award PMEA 2019

Press Releases | November 29, 2019 | Four Agency Worldwide

We’re delighted to have won the Judge’s Special Recognition Award at the PMEA Awards 2019! Huge congratulations to the whole team for another amazing win for the GLAD I Took...

Lucid Group announces the appointment of a new Legal and Compliance manager

Press Releases | November 27, 2019 | Lucid Group Communications Limited

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

Press Releases | November 27, 2019 | Lucid Group Communications Limited

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

White Papers and Resources | November 27, 2019 | OPEN Health

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Bedrock’s on fire for Wellbeing Week

Press Releases | November 26, 2019 | Bedrock Healthcare Communications

Bedrock creates a positive working environment to enable individuals and our business to thrive.